Locations:
Search
A multidisciplinary team of Cleveland Clinic scientists looks to evolution for answers
Drug beats standard care for the treatment of relapsed or refractory ALL
APE2 may hold the key to reducing cisplatin toxicity
Endoluminal surgery provides new treatment options
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Pairing low-frequency ultrasound with microbubble resonators to penetrate the blood-brain barrier
Slight deviation from treatment paradigm salvages significant anatomy
Large validation study corroborates previous findings, sets the stage for clinical use
Truly personalized radiotherapy may be within reach
Molecular targeted therapies and other treatments offer new options
Recurrence and outcomes for stage II disease are worse than in ever-smokers
Advertisement
Advertisement